World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
120
Citations
62853
World Ranking
3703
National Ranking
2040

Inder S. Anand publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Inder S. Anand sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 594 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Inder S. Anand D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Inder S. Anand sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 120 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Inder S. Anand is affiliated with the University of Minnesota in the United States. Their research focuses primarily on Medicine, with a significant emphasis on Cardiology and Cardiovascular Medicine. Other subfields include Endocrinology, Diabetes and Metabolism, Surgery, Neurology, and Pulmonary and Respiratory Medicine.

Anand's work covers various topics within these fields. Notable areas of study include:

  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Diabetes Treatment and Management
  • Cardiac Pacing and Defibrillation Studies
  • Vagus Nerve Stimulation Research
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control

The scientist has published extensively, with frequent appearances in leading cardiovascular journals. The most common publication venues include:

  • Circulation
  • Journal of the American College of Cardiology
  • JACC Heart Failure
  • European Heart Journal
  • European Journal of Heart Failure

Among their recent notable papers are:

  • "Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure" (2020), published in New England Journal of Medicine
  • "Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes" (2020), published in JAMA
  • "Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction" (2020), published in Circulation
  • "A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction" (2021), published in JACC Heart Failure
  • "Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial" (2021), published in Circulation

Anand has collaborated frequently with several researchers in the cardiovascular field. Their most frequent coauthors include:

  • John J.V. McMurray
  • Scott D. Solomon
  • Pardeep S. Jhund
  • Akshay S. Desai
  • Michael R. Zile

Best Publications

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • The Seattle Heart Failure Model Prediction of Survival in Heart Failure

    Wayne C. Levy;Dariush Mozaffarian;David T. Linker;Santosh C. Sutradhar

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

    Claudio Ronco;Peter R. McCullough;Stefan D. Anker;Inder Anand

  • Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

    Inder S. Anand;Lloyd D. Fisher;Yann Tong Chiang;Roberto Latini

  • Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Marc A. Pfeffer;Brian Claggett;Susan F. Assmann;Robin Boineau

  • Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

    Roberto Latini;Roberto Latini;Serge Masson;Inder S. Anand;Emil Missov

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Karl Swedberg;James B. Young;Inder S. Anand;Sunfa Cheng

  • Anemia and Its Relationship to Clinical Outcome in Heart Failure

    Inder Anand;John J.V. McMurray;James Whitmore;Marshelle Warren

  • Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea : results from the BACH (Biomarkers in Acute Heart Failure) trial

    Alan Maisel;Christian Mueller;Richard Nowak;W. Frank Peacock

  • C-Reactive Protein in Heart Failure Prognostic Value and the Effect of Valsartan

    Inder S. Anand;Roberto Latini;Roberto Latini;Viorel G. Florea;Michael A. Kuskowski

  • Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.

    Bradley A. Bart;Andrew Boyle;Alan J. Bank;Inder Anand

  • Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

    Aldo P Maggioni;Inder Anand;Sidney O Gottlieb;Roberto Latini

  • Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

    Sheryl L. Chow;Alan S. Maisel;Inder Anand;Biykem Bozkurt

  • Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

    Amil M. Shah;Sanjiv J. Shah;Inder S. Anand;Nancy K. Sweitzer

  • Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

    Scott D. Solomon;Brian Claggett;Eldrin F. Lewis;Akshay Desai

  • Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    John R. Teerlink;Rafael Diaz;G. Michael Felker;John J.V. McMurray

  • Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.

    Inder Anand;John McMurray;Jay N Cohn;Marvin A Konstam

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
John J.V. McMurray
John J.V. McMurray University of Glasgow
Jay N. Cohn
Jay N. Cohn University of Minnesota
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Carolyn S.P. Lam
Carolyn S.P. Lam National University of Singapore
Michael R. Zile
Michael R. Zile Medical University of South Carolina
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
Roberto Latini
Roberto Latini Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the healthcare field but not sure if medical school is right for you? There are numerous online pathways that can help you start or advance a career in medicine, nursing, or healthcare management.

For those who already hold an RN license and want to advance their education, the cheapest rn to bsn program online can be an affordable way to earn a bachelor’s degree and improve career prospects. If you hold a non-nursing bachelor's degree and are looking to transition into nursing, consider non nursing bachelor's to msn online programs, which provide a pathway to acquire a master’s in nursing, even without an undergraduate background in the field.

For aspiring nurses seeking the fastest entry, there are many accredited adn nursing programs that offer a direct route into professional practice. Those aiming for advanced roles such as educators or nurse practitioners may want to explore online nursing doctoral programs to achieve the highest credentials.

Exploring these online degrees and alternative pathways can help you find the right fit for your goals in the dynamic U.S. healthcare landscape.

Best Scientists Citing Inder S. Anand

Trending Scientists

Recently Published Articles